BioXcel Therapeutics
BTAI
#10116
Rank
โ‚ฌ9.08 M
Marketcap
1,66ย โ‚ฌ
Share price
-8.54%
Change (1 day)
-95.75%
Change (1 year)

EPS for BioXcel Therapeutics (BTAI)

EPS in 2024 (TTM): -1,98ย โ‚ฌ

According to BioXcel Therapeutics's latest financial reports the company's current EPS (TTM) is -1,97ย โ‚ฌ. In 2023 the company made an earnings per share (EPS) of -5,60ย โ‚ฌ a decrease over its 2022 EPS that were of -5,38ย โ‚ฌ.

EPS history for BioXcel Therapeutics from 2020 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-1,98ย โ‚ฌ-64.72%
2023-5,60ย โ‚ฌ4.06%
2022-5,38ย โ‚ฌ44.85%
2021-3,71ย โ‚ฌ7.65%
2020-3,45ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-1,98ย โ‚ฌ 0.93%๐Ÿ‡บ๐Ÿ‡ธ USA